Amylin: difference between revisions
Diff·revision 14 → 15·14:22, 24 Feb 2025
Difference between revision 14 and revision 15 of Amylin. 2 lines changed; the page grew by 296 bytes.
| Revision 14 — 23:50, 5 Feb 2025 LiraLotte (talk) expand §Receptors 3,956 bytes +23 | Revision 15 — 14:22, 24 Feb 2025 TrialsTabitha (talk) reorder the analogues chronologically rather than alphabetically 4,252 bytes +296 | ||
|---|---|---|---|
| 37 | | AMY3 | CTR + RAMP3 | Widely distributed | | 37 | | AMY3 | CTR + RAMP3 | Widely distributed | |
| 38 | 38 | ||
| + | 39 | Because the receptor family overlaps with that for calcitonin and calcitonin gene-related peptide, selectivity is a real design constraint for analogues, and cross-activity at the calcitonin receptor is one route by which a long-acting analogue can produce effects beyond appetite.{{r|hay2015}} | |
| + | 40 | ||
| 39 | == References == | 41 | == References == |
| 40 | {{reflist}} | 42 | {{reflist}} |